Dr. Menge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Park Nicollet Blvd
Saint Louis Park, MN 55416Phone+1 952-993-3248
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2001 - 2004
Hennepin HealthcareResidency, Internal Medicine, 1997 - 2001- University of Minnesota Medical SchoolClass of 1997
Certifications & Licensure
MN State Medical License 2000 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 83 citationsNab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial.Vaibhav Sahai, Paul J. Catalano, Mark M. Zalupski, Sam J. Lubner, Mark R. Menge
JAMA Oncology. 2018-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
